Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy

Ophthalmic Surgery Lasers and Imaging

Volumn 42, Issue 6, 2011, Pages 474-480

  Schoenberger, Scott D ^a   Miller, Daniel M ^a,b   Riemann, Christopher D ^a,b   Foster, Robert E ^b   Sisk, Robert A ^a,b   Hutchins, Robert K ^a,b   Petersen, Michael R ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB;

ARTICLE; CHOROID DISEASE; CILIARY DISK; DIABETIC RETINOPATHY; DISEASE SEVERITY; FOLLOW UP; HUMAN; INTRAOCULAR HYPOTENSION; IRIS RUBEOSIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARS PLANA VITRECTOMY; PRIORITY JOURNAL; RETINA DETACHMENT; RHEGMATOGENOUS RETINAL DETACHMENT; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITRECTOMY;

EID: 83055174618     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20110901-02     Document Type: Article

References (40)

1. Fujii GY, de Juan E Jr, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109:1814-1820.
2. Kellner L, Wimpissinger B, Stolba U, Brannath W, Binder S. 25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomized clinical trial. Br J Ophthalmol. 2007;91:945-948. (Pubitemid 47013110)
3. Lakhanpal RR, Humayun MS, de Juan E Jr, et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology. 2005;112:817-824. (Pubitemid 40631500)
4. Byeon SH, Chu YK, Lee SC, Koh HJ, Kim SS, Kwosn OW. Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery. Ophthalmologica. 2006;220:259-265.
5. Bahar I, Axer-Siegel R, Weinberger D. Pars plana vitrectomy: comparison of three techniques for the treatment of diabetic vitreous hemorrhage. Ophthalmic Surg Lasers Imaging. 2006;37:364-369. (Pubitemid 44519240)
6. Okuda T, Nishimura A, Kobayashi A, Sugiyama K. Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases. Graefes Arch Clin Exp Ophthalmol. 2007;245:155-157. (Pubitemid 46766742)
7. Ibarra MS, Hermel M, Prenner JL, Hassan TS. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol. 2005;139:831-836. (Pubitemid 40614769)
8. Von Fricken MA, Kunjukunju N, Weber C, Ko G. 25-gauge sutureless vitrectomy versus 20-gauge vitrectomy for the repair of primary rhegmatogenous retinal detachment. Retina. 2009;29:444-450.
9. Acar N, Unver YB, Altan T, Kapran Z. Acute endophthalmitis after 25-gauge sutureless vitrectomy. Int Ophthalmol. 2007;27:361-363. (Pubitemid 350090640)
10. Byeon SH, Lew YJ, Kim M, Kwon OW. Wound leakage and hypotony after 25-gauge sutureless vitrectomy: factors affecting postoperative intraocular pressure. Ophthalmol Surg Lasers Imaging. 2008;39:94-99. (Pubitemid 351619783)
11. Yang SJ, Yoon SY, Kim J, Yoon YH. Transconjunctival sutureless vitrectomy for the treatment of vitreoretinal complications in patients with diabetes mellitus. Ophthalmol Surg Lasers Imaging. 2009;40:461-466.
12. Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009;116:927-938.
13. Rizzo S, Genovesi-Ebert F, Vento A, Miniaci S, Cresti F, Palla M. Modified incision in 25-gauge vitrectomy in the creation of a tunneled airtight sclerotomy: an ultrabiomicroscopic study. Graefes Arch Clin Exp Ophthalmol. 2007;245:1281-1288. (Pubitemid 47278664)
14. Acar N, Kapran Z, Unver YB, Altan T, Ozdogan S. Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. Retina. 2008;28:545-552. (Pubitemid 351589562)
15. Gupta OP, Weichel ED, Regillo CD, et al. Postoperative complications associated with 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging. 2007;38:270-275. (Pubitemid 47280424)
16. Branisteanu D, Danielescu C, Irimia A, Robu M. Efficiency of air tamponade in prevention of early recurrence of vitreal hemorrhage in diabetic vitreous hemorrhage. Oftalmologia. 2006;50:62-67.
17. Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. Ophthalmology. 1983;90:522-530.
18. Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy. Curr Eye Res. 2010;35:308-313.
19. Mason JO 3rd, Colagross CT, Haleman T, et al. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 2005;140:231-235.
20. Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92:365-368. (Pubitemid 351363532)
21. Aaberg TM. Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology. 1981;88:639-642. (Pubitemid 11087724)
22. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1989;96:1495-1500. (Pubitemid 19250960)
23. Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology. 1984;91:1485-1489. (Pubitemid 15197020)
24. Smiddy WE, Feuer W, Irvine D, Flynn HW Jr, Blankenship GW. Vitrectomy for complications of proliferative diabetic retinopathy. Functional Outcomes. Ophthalmology. 1995;102:1688-1695.
25. West JF, Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol. 2000;84:822-825. (Pubitemid 30599084)
26. Hershberger VS, Augsburger JJ, Hutchins RK, Raymond LA, Krug S. Fibrovascular ingrowth at sclerotomy sites in vitrectomize diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.Ophthalmology. 2004;111:1215-1221. (Pubitemid 38737003)
27. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL, The Early Treatment Diabetic Retinopathy Study Research Group. Pars plana vitrectomy in the early treatment diabetic retinopathy study. ETDRS Report Number 17. Ophthalmology. 1992;99:1351-1357.
28. Krieger AE. The pars plana incision: in experimental studies, pathologic observations, and clinical experience. Trans Am Ophthalmol Soc. 1991;89:549-621.
29. Hotta K, Hirakata A, Ohi Y, et al. Ultrasound biomicroscopy for examination of the sclerotomy site in eyes with proliferative diabetic retinopathy after vitrectomy. Retina. 2000;20:52-58. (Pubitemid 30387466)
30. Yang CM, Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology. 2007;114:710-715. (Pubitemid 46483680)
31. Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology. 2009;116:1943-1948.
32. Yeung L, Liu L, Wu WC, et al. Reducing the incidence of early postoperative vitreous hemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Acta Ophthalmol. 2010;88:635-640.
33. Yang CM, Yeh PT, Yang CH, Chen MS. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol. 2008;146:211-217.
34. Jonas JB, Schmidbauer M, Rensch F. Progression of tractional retinal detachment following intravitreal bevacizumab. Acta Ophthalmol. 2009;87:571-572.
35. Tao Y, Jiang YR, Li XX, Gao L, Jonas JB. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30:447-451.
36. Helbig H, Kellner U, Bornfeld N, Foerster MH. Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1998;236:730-733. (Pubitemid 28458671)
37. Schrey S, Krepler K, Wedrich A. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina. 2006;26:149-152. (Pubitemid 44400708)
38. Rizzo S, Genovesi-Ebert F, Murri S, et al. 25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol. 2006;244:472-479.
39. Okamoto F, Okamoto C, Sakata N, et al. Changes in corneal topography after 25-gauge transconjunctival sutureless vitrectomy versus after 20-gauge standard vitrectomy. Ophthalmology. 2007;114:2138-2141. (Pubitemid 350181103)
40. Galway G, Drury B, Cronin BG, Bourke RD. A comparison of induced astigmatism in 20- vs 25-gauge vitrectomy procedures. Eye. 2010;24:315-317.